摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl-2-<<4-(1H-imidazol-1-yl)phenyl>oxy>-2-methylpropanoate | 95923-64-1

中文名称
——
中文别名
——
英文名称
ethyl-2-<<4-(1H-imidazol-1-yl)phenyl>oxy>-2-methylpropanoate
英文别名
ethyl 2-[p-(1-imidazolyl)phenoxy]-2-methylpropionate;ethyl 2-(4-imidazol-1-ylphenoxy)-2-methylpropanoate
ethyl-2-<<4-(1H-imidazol-1-yl)phenyl>oxy>-2-methylpropanoate化学式
CAS
95923-64-1
化学式
C15H18N2O3
mdl
——
分子量
274.32
InChiKey
VVBUSRDBEYFZSY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    405.5±25.0 °C(Predicted)
  • 密度:
    1.11±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    20
  • 可旋转键数:
    6
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    53.4
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] WNT PATHWAY MODULATORS<br/>[FR] MODULATEURS DE LA VOIE WNT
    申请人:AGENCY SCIENCE TECH & RES
    公开号:WO2014175832A1
    公开(公告)日:2014-10-30
    The invention provides a compound of structure Ar1-Ar2-X-C(R1R2)-C(=O)-N(R3)-Ar3-Ar4 for modulating WNT activity. In this structure, Ar1, Ar2, Ar3 and Ar4 are, independently, optionally substituted aryl or heteroaryl groups; R1 and R3 are, independently, H or optionally substituted alkyl groups; R2 is H or an optionally substituted alkyl group or an alkylene group which, together with the carbon atom to which it is attached and X, forms a non-aromatic ring or an alkylene group which, together with the carbon atom to which it is attached and X and two adjacent atoms of Ar2, forms a non-aromatic ring; X is O, CR4R5, N or NR4, wherein if X is N, it is bonded to R2; R4 is H, optionally substituted alkyl or an alkylene chain, optionally containing a heteroatom and/or a carbonyl group, which, together with the C or N to which it is attached and two adjacent atoms of Ar2, forms a non-aromatic ring; R5 is H, NH2 or an optionally substituted alkyl group.
    该发明提供了一种结构为Ar1-Ar2-X-C(R1R2)-C(=O)-N(R3)-Ar3-Ar4的化合物,用于调节WNT活性。在这种结构中,Ar1、Ar2、Ar3和Ar4分别是可选择取代的芳基或杂环芳基;R1和R3分别是H或可选择取代的烷基;R2是H或可选择取代的烷基或与其连接的碳原子和X形成非芳香环的烷基,或者与其连接的碳原子、X和Ar2的两个相邻原子形成非芳香环的烷基;X是O、CR4R5、N或NR4,如果X是N,则与R2相结合;R4是H、可选择取代的烷基或含有杂原子和/或羰基的烷基链,与其连接的C或N以及Ar2的两个相邻原子形成非芳香环;R5是H、NH2或可选择取代的烷基。
  • Imidazolyl phenoxy compounds and method of use
    申请人:Yamanouchi Pharmaceutical Co., Ltd.
    公开号:US04794113A1
    公开(公告)日:1988-12-27
    Imidazolyl phenoxy derivatives are provided as well as pharmaceutical compositions containing such derivatives. The compositions useful for lowering lipid activity in a subject and accordingly useful for reducing cholesterol and triglycerides.
    咪唑基苯氧衍生物以及含有这种衍生物的药物组合物被提供。这些组合物对于降低受试者的脂质活性有用,因此对于降低胆固醇和甘油三酯有用。
  • Certain thiazol-4-yl-phenoxy derivatives having lipid lowering properties
    申请人:——
    公开号:US04942242A1
    公开(公告)日:1990-07-17
    Thiazolyl phenoxy derivatives are provided as well as pharmaceutical compositions containing such derivatives. The compositions are useful for lowering lipid activity in a subject and accordingly useful for reducing cholesterol and triglycerides.
    提供了噻唑基苯氧衍生物,以及含有这些衍生物的药物组合物。这些组合物对于降低受试者的脂质活性非常有用,因此有助于降低胆固醇和甘油三酯。
  • Certain pyridyl or imidazol-1-yl-alkyleneoxy-(or
    申请人:Yamanouchi Pharmaceutical Co., Ltd.
    公开号:US04795753A1
    公开(公告)日:1989-01-03
    The present invention relates to novel phenoxy derivatives represented by the formula (I): ##STR1## wherein: A is an imidazolyl group, a pyridyl group, a pyridyloxy group, B is group represented by the formula: --(CH.sub.2).sub.n --O--, --(CH.sub.2).sub.n CONH(CH.sub.2).sub.k -- or --(CH.sub.2).sub.n-N (R.sup.4)-- wherein k is 0 or an integer of 1 to 5, n is an integer of 1 to 6 and R.sup.4 is hydrogen or a lower alkyl group; m is 0 or an integer of 1 to 6; R.sup.1 is a hydroxyl group, an amino group or a lower alkoxy group; R.sup.2 and R.sup.3 which may be the same or different represent, a hydrogen atom or a lower alkyl group hereafter the same, having lipid lowering activity, and salts thereof.
    本发明涉及由公式(I)表示的新的苯氧衍生物:##STR1## 其中:A是咪唑基,吡啶基,吡啶氧基,B是由公式表示的基团:--(CH.sub.2).sub.n--O--,--(CH.sub.2).sub.nCONH(CH.sub.2).sub.k--或--(CH.sub.2).sub.n-N(R.sup.4)--,其中k为0或1至5的整数,n为1至6的整数,R.sup.4为氢或较低的烷基;m为0或1至6的整数;R.sup.1为羟基,氨基或较低的烷氧基;R.sup.2和R.sup.3可以相同也可以不同,表示氢原子或较低的烷基,具有降脂作用,以及其盐。
  • Certain pyridinyl or imidazolinyl-4-thiazolyl-phenoxy alkanoic acid
    申请人:Yamanouchi Pharmaceutical Co., Ltd.
    公开号:US04798838A1
    公开(公告)日:1989-01-17
    The present invention relates to novel phenoxy derivatives represented by the formula (I): ##STR1## wherein: A is an imidazolyl group, a pyridyl group, a pyridyloxy group, an oxo-substituted chromenyloxy group, a lower alkyl group, an amino group which may be substituted with a phenyl group or a lower alkyl group, or a carbamoyl group substituted with a cyclohexylamino group or an imidazolylalkyl group; B is a single bond, a thiazolyl group which may be substituted with a lower alkyl group, a group represented by the formula: --(CH.sub.2).sub.n --O--, --(CH.sub.2).sub.n CONH(CH.sub.2).sub.k -- or --(CH.sub.2).sub.n --N(R.sup.4)-- wherein k is 0 or an integer of 1 to 5, n is an integer of 1 to 6 and R.sup.4 is hydrogen or a lower alkyl group; m is 0 or an integer of 1 to 6; R.sup.1 is a hydroxyl group, an amino group or a lower alkoxy group; R.sup.2 and R.sup.3 which may be the same or different, represent a hydrogen atom or a lower alkyl group hereafter the same: and salts thereof. In the definition of the groups appearing in the formulae in the specification, the term "lower" refers to a straight or branched carbon chain having 1 to 5 carbon atoms, preferably 1 to 3 carbon atoms. Accordingly, specific examples of lower alkyl groups include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, a pentyl (or amyl) group, an isopentyl group, a neopentyl group, a tert-pentyl group, etc.
    本发明涉及由式(I)表示的新型苯氧衍生物:##STR1## 其中:A是咪唑基团,吡啶基团,吡啶氧基团,氧代取代的香豆素氧基团,低碳基,氨基,该氨基可以被苯基或低碳基取代,或者是用环己氨基基团或咪唑基烷基基团取代的氨甲酰基基团;B是单键,可以被低碳基取代的噻唑基团,或由式表示的基团:--(CH.sub.2).sub.n --O--,--(CH.sub.2).sub.n CONH(CH.sub.2).sub.k --或--(CH.sub.2).sub.n --N(R.sup.4)--,其中k为0或1至5的整数,n为1至6的整数,R.sup.4为氢或低碳基;m为0或1至6的整数;R.sup.1为羟基,氨基或低烷氧基;R.sup.2和R.sup.3可以相同也可以不同,在此后均表示氢原子或低碳基;以及其盐。在规范中出现的基团的定义中,“低”一词是指具有1至5个碳原子的直链或支链碳链,最好是1至3个碳原子。因此,低碳基的具体例子包括甲基基团,乙基基团,丙基基团,异丙基基团,丁基基团,异丁基基团,仲丁基基团,叔丁基基团,戊基(或戊基)基团,异戊基基团,新戊基基团,叔戊基基团等。
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺